Curzon Consulting

MARCH 8, 2024

5 Minutes We’re almost through the first quarter of 2024, and the airwaves are still buzzing with predictions about the major trends that will dominate our business landscape. This analysis summarises the major trends identified in various industry publications, providing a comprehensive business outlook for 2024 – the “means”.

Consulting 40

Consulting Competition Ethics Management 40

Eversana Intouch

NOVEMBER 20, 2023

As we step into 2024, the realm of market access undergoes dynamic shifts influenced by technological advancements, policy changes, and evolving consumer behaviors. As we traverse through 2024, businesses must adapt to these emerging trends in market access. That is, the use of generative AI and the prioritization of health equity.

Marketing 83

Marketing Healthcare Healthcare Pharma 83

PharmaVoice

JANUARY 24, 2024

Executives on the healthcare giant’s full-year earnings call highlighted a strong cash position and incremental dealmaking as a way to get past incoming competition.

Competition 98

Competition Healthcare Healthcare 98

European Pharmaceutical Review

JANUARY 11, 2024

Ustekinumab biologic Once the European Supplementary Protection Certificate (SPC) for Stelara expires in July 2024, this will open up market entry as soon as possible for Uzpruvo, now that it is approved in Europe” Ustekinumab is a human IgG1κ monoclonal antibody (mAb). The EU ustekinumab market is worth €2.5

Competition 97

Competition Marketing Safety Manufacturing 97

Clarivate

DECEMBER 19, 2022

Expansion opportunities for 2024 are relatively obvious, since the partners could expand to the three states with Walmart Health locations (Arkansas, Illinois, Texas ). Either way, competition over employed providers among Medicare Advantage plans has only begun to heat up and UnitedHealth remains the plan to beat.

Competition 52

Competition Retail Insurance Marketing 52

Spotio

NOVEMBER 20, 2023

Speaking of… Perform A Thorough Competitive Analysis A competitive analysis will help you identify your competitors, pinpoint their strengths and weaknesses, and implement a reliable plan to overcome them in the marketplace.

Retail 52

Retail Distribution Sales Manufacturing 52

Copyright Clearance Center

APRIL 9, 2024

April 9, 2024 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, has been named to the Top Workplaces USA 2024 list by USA Today for the third consecutive year. It’s a morale-boosting honor for the workforce and an effective magnet for attracting top-tier talent.”

Education 64

Education Competition Marketing 64

LEVO Health

APRIL 18, 2024

This year, we’re thrilled to take our commitment a step further by sponsoring the 2024 HealthTech|X Accelerator program hosted by Tampa Bay Wave. These resources are invaluable for young companies looking to scale and make their mark in the competitive health tech landscape.

Healthcare 98

Healthcare Healthcare Competition Training 98

European Pharmaceutical Review

NOVEMBER 2, 2023

Sustainable biosimilar competition in Europe: can it be achieved? We do not expect entry of Stelara biosimilars in the United States during 2024,” Joseph Wolk CFO, Johnson & Johnson, stated during the company’s Q3 earnings call on 18 October. US sales of Stelara totalled $6.4

Food and Drug Administration 86

Food and Drug Administration FDA Side effects Safety 86

PM360

SEPTEMBER 21, 2023

They do not have biosimilar or generic competition available in the market. CMS will present an initial offer for each drug’s maximum fair price (MFP) by February 1, 2024. The MFPs will be announced publicly in September 2024 and go into effect on January 1, 2026. They do not qualify for any exemption (e.g.,

Manufacturing 111

Manufacturing Competition Marketing Physicians 111

European Pharmaceutical Review

APRIL 19, 2024

Conclusions from the meeting of the special European Council (17-18 April 2024) have recognised a need for new European competitiveness deal “anchored in a fully integrated Single Market”. The post Enhancing competitiveness of European life sciences appeared first on European Pharmaceutical Review.

Competition 83

Competition Manufacturing Specialization Pharmaceutical 83

Legacy MEDSearch

MARCH 7, 2024

Dexcom disclosed its plans to make Stelo available for purchase online without the need for a prescription, starting in summer 2024. The company aims to offer the device at a competitive price point, but further pricing details will be shared closer to the product’s release date.

Food and Drug Administration 52

Food and Drug Administration FDA Food Management 52

PM360

DECEMBER 20, 2023

Learn more about why each company went with its respective strategy and the current outlook for each company in 2024 and beyond. The deal is expected to close in 2024. Many investors also prioritize companies with a substantial market opportunity and a unique product, particularly in competitive markets or crowded therapeutic areas.

Management 109

Management Marketing Healthcare Healthcare 109

Star OUTiCO

DECEMBER 11, 2023

Going forward into 2024 there are some exciting things which I’m keen to get stuck into. Candidates really need to set themselves apart from their competition. The next thing that I found exciting about Star OUTiCO is the opportunity to work within a much wider group. I like doing anything outdoorsy!

Recruitment 52

Recruitment Consulting Competition Specialization 52

Healthcare Success

APRIL 8, 2024

As an engineering undergrad, I took a Marketing 101 class on a lark, seeking to better understand the psychology behind consumer behavior and developing products with a competitive edge. The 7 tactics of marketing can help you: Develop a competitive advantage. Promote that competitive edge with vigor. Reach a broader audience.

Marketing 112

Marketing Competition Patients Healthcare 112

European Pharmaceutical Review

JULY 18, 2022

Nebido is also patented until March 2024 in the European Union and until May 2027 in the United States. The deal is expected to close by the end of 2022, subject to approval by the relevant competition authorities. The long-acting injectable treatment for testosterone deficiency has been commercially approved in more than 80 countries.

Medicine 79

Medicine Physicians Competition Patients 79

Clarify Health

JANUARY 16, 2024

in 2024, according to a report from Mercer — and that projection includes changes employers plan to make to hold down costs. Employers are struggling under the weight of increasing healthcare costs for their employees — and are turning to third-party administrators to help. If no changes were made, costs would rise 6.6%.

Networking 52

Networking Healthcare Healthcare Insurance 52

PM360

DECEMBER 20, 2023

With 2024 on the horizon, many in the biopharma space are taking stock of 2023 and what the current environment means for their potential success next year. This allows for a complementary portfolio fit without the kind of competitive overlap that comes under regulatory scrutiny from the FTC.

Biopharma 111

Biopharma Pharma Marketing Management 111

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 89

Medicine Healthcare Healthcare Pharma 89

PM360

SEPTEMBER 21, 2023

Attention deficit hyperactivity disorder (ADHD) drug Vyvanse (lisdexamfetamine dimesylate) , manufactured by Takeda, also is facing generic competition. In the respiratory area with inhalers, it’s tough to get drugs approved, so the competition comes slowly,” he said. In 2024, ARPA removes the 100% AMP cap.

Management 105

Management Manufacturing Sales Competition 105

pharmaphorum

JANUARY 16, 2023

The bi-weekly intramuscular shot – which was also approved in China in 2021 – will enter a crowded market for long-acing injectable (LAI) schizophrenia therapies in the US and have to take on heavyweight competition, including drugs that require less frequent dosing.

FDA 52

FDA Pharma Marketing Competition 52

pharmaphorum

JANUARY 13, 2023

California Attorney General Rob Bonta (pictured above) said the conduct of the companies amounts to unlawful and deceptive business practices that violate the state’s unfair competition laws. The suit follows legal action over insulin pricing taken by other states, including Arkansas , Kansas, Mississippi, and Minnesota.

Manufacturing 102

Manufacturing Patients Competition Medical 102

pharmaphorum

JULY 11, 2022

The company had been eyeing a possible regulatory filing for fitusiran this year, but has now set back the timeline – possibly until 2024 – while it gathers data on the revised dosing schedule, in the hope of maintaining efficacy with fewer clotting side effects. Sanofi acquired the drug when it bought Bioverativ in 2018 for $11.6

Engineering 52

Engineering Side effects Competition Sales 52

Clarivate

DECEMBER 6, 2022

In a fiercely competitive U.S. While marquee IDNs attract national headlines, these smaller systems reflect how markets are adjusting to an increasingly value-based and competitive landscape. ChristianaCare’s future expansion plans could escalate the competition between Highmark and UPMC. ChristianaCare, Wilmington, Delaware.

Networking 52

Networking Healthcare Healthcare Competition 52

pharmaphorum

JULY 11, 2022

Tremfya is being positioned as a successor to $9 billion-a-year blockbuster Stelara – which is due to start losing patent protection next year in the US and 2024 in Europe – but while it is growing fast looks unlikely to reach the heights of its predecessor.

Patients 52

Patients Competition Marketing Sales 52

pharmaphorum

NOVEMBER 1, 2022

“We believe that the top-line results as reported in and of themselves do not appear to appreciably differentiate NCX-470’s IOP-lowering competitive profile as a monotherapy” from current therapies like latanoprost and bimatoprost, he said in a research note.

Competition 52

Competition Safety FDA Leads 52

Pharmaceutical Technology

OCTOBER 28, 2022

There, the business plans to submit an IND application for a Phase I/II in the second half of 2023, with a readout in 2024. Competition in an increasingly heated market. Vaxcyte’s recent clinical success brings further competition into a sector, which is becoming increasingly heated.

Training 64

Training Marketing Competition FDA 64

pharmaphorum

JULY 15, 2022

At the time, she said, “companies have to respect our competition rules and procedures. If it proves effective in the trial, the UK has said it could roll testing out to one million people in 2024 and 2025.

Competition 52

Competition Medicine Marketing Sales 52

Nixon Gwilt Law

JANUARY 16, 2024

What can digital health innovators and investors anticipate for the industry in 2024? What can digital health innovators and investors anticipate for the industry in 2024? Read on to find out what else is on our Legal Vision Board for 2024! How is 2024 Shaping up for Your Business?

Healthcare 52

Healthcare Healthcare Management Insurance 52

PM360

APRIL 7, 2023

However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position. Expect the nine competitors to explore Kotler’s 4Ps of Marketing to gain share in this lucrative and competitive marketplace.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

pharmaphorum

NOVEMBER 17, 2022

Leela Barham argues that more transparency at a minimum is required next time around, should a VPAS style of agreement be agreed upon for 2024 onwards, and perhaps even a more radical re-think about how a deal is struck in the future. Predictable for government. Being forewarned is being forearmed after all.

Government 95

Government Sales Medicine Consulting 95

Clarivate

DECEMBER 18, 2023

The full case study can be found here: A new global IP team with a tailored strategy for success.   White Paper: Investing in innovative IP legal strategies during challenging times Budgets and staffing are tight, competitive pressures are on the rise, and clients and business leaders are demanding more for less—without compromising quality.

Specialization 59

Specialization Management Consulting Competition 59

Star OUTiCO

DECEMBER 1, 2023

It’s a time to unwind and reflect on the year that has passed, and also is a great opportunity to take stock of your career and prepare for the exciting job possibilities that 2024 holds. Our Star OUTiCO consultants are ready to guide you through the process. Establish clear and achievable job search goals for the upcoming year.

Pharma 52

Pharma Recruitment Networking Consulting 52

Pharmaceutical Technology

JANUARY 10, 2023

Type 2 diabetes (T2D) is a crowded and competitive landscape with multiple “me-too,” generic and biosimilar drugs entering the market, with market growth primarily driven by an increasing prevalent population across nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, China, and India).

Marketing 52

Marketing Physicians Leads Competition 52

pharmaphorum

NOVEMBER 25, 2022

The Parma site, as yet only nine months into construction, is due to become operational from 2024, with FDA, IFA, and EMA approvals due to be sought for 2025. In brief, the European plan for Chiesi is in-house drug development of biologicals and rare disease targeting. The situation was reversed only 25 years ago.

Pharmaceutical 92

Pharmaceutical Manufacturing Medicine Competition 92

PM360

NOVEMBER 13, 2023

Reason 3: By the Numbers, GoodRx Is One of the Most Trusted Sources at the Point of Prescribing According to global communications firm Edelman, “For a business… lasting trust is the strongest insurance against competitive disruption, the antidote to consumer indifference, and the best path to continued growth.”

Media 52

Media Prescription Healthcare Provider Patients 52

Spotio

JANUARY 9, 2024

When you generate proposals faster than the competition, you’ll be top of mind when your prospect is ready to make a purchase. That way you can iterate your proposals as necessary. More Sales : At the end of the day, solar proposal tools help close more deals. It makes sense.

Prospecting 52

Prospecting Sales Distribution Sales process 52